[1]邓 佳,赵文生,李孝林,等.基于数据挖掘和网络药理学研究徐昌伟治疗腰椎间盘突出症的用药规律及作用机制[J].医学信息,2025,38(05):16-25.[doi:10.3969/j.issn.1006-1959.2025.05.003]
　DENG Jia,ZHAO Wensheng,LI Xiaolin,et al.Medication Rules and Mechanism of XU Changwei in the Treatment of Lumbar Disc Herniation Based on Data Mining and Network Pharmacology[J].Journal of Medical Information,2025,38(05):16-25.[doi:10.3969/j.issn.1006-1959.2025.05.003]
点击复制

基于数据挖掘和网络药理学研究徐昌伟治疗腰椎间盘突出症的用药规律及作用机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年05期
页码:
16-25
栏目:
中医药信息学
出版日期:
2025-03-01

文章信息/Info

Title:
Medication Rules and Mechanism of XU Changwei in the Treatment of Lumbar Disc Herniation Based on Data Mining and Network Pharmacology
文章编号:
1006-1959（2025）05-0016-10
作者:
邓 佳1; 赵文生1; 李孝林2; 陈洪卫3; 彭昌华3; 王华东1; 3; 张朝驹3; 何 川1; 3
1.湖北中医药大学针灸骨伤学院，湖北 武汉 430061；2.长江大学医学部，湖北 荆州 434023；3.湖北中医药大学附属荆州市中医医院骨科，湖北 荆州 434000
Author(s):
DENG Jia1;  ZHAO Wensheng1;  LI Xiaolin2;  CHEN Hongwei3;  PENG Changhua3;  WANG Huadong1; 3;  ZHANG Chaoju3;  HE Chuan1; 3
1.College of Acupuncture and Moxibustion and Orthopedics, Hubei University of Chinese Medicine, Wuhan 430061, Hubei, China;2.Yangtze University Health Science Center, Jingzhou 434023, Hubei, China;3.Department of Orthopaedics, Jingzhou Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Chinese Medicine, Jingzhou 434000, Hubei, China
关键词:
名老中医经验; 腰椎间盘突出症; 数据挖掘; 用药规律; 作用机制
Keywords:
Experience of famous old Chinese medicine;  Lumbar disc herniation;  Data mining;  Medication rules;  Mechanism of action
分类号:
R723.14
DOI:
10.3969/j.issn.1006-1959.2025.05.003
文献标志码:
A
摘要:
目的 探讨徐昌伟教授治疗腰椎间盘突出症的用药规律及作用机制。方法 搜集徐昌伟教授2010-2018年于荆州市中医医院门诊治疗腰椎间盘突出症的病例资料，运用“中医传承辅助平台（V3.5）”对数据进行频数分析和关联分析，获得核心处方，并对其进行网络药理学分析。运用TCMSP数据库获取核心组方中药活性成分，利用Gene Cards、OMIM数据库筛选疾病靶点并生成韦恩图，使用Cytoscape3.9.2软件构建核心网络。运用Metascape在线数据库对获得的关键靶点进行GO、KEGG功能富集分析。运用Autodock程序进行对接，通过PyMOL实现结果的可视化。结果 共录入200个病例，处方涉及179味中药，高频药物10味，温、平性药物运用最多，多归肝、脾、肾三经，性味以辛、苦、甘多见；关联规则得到60条数据，聚类分析得到3组核心组合。4种核心药物（川芎、当归、杜仲、牛膝）中核心活性成分共59个，靶点基因144个，疾病靶点613个，药物-疾病共同靶点共40个。GO功能富集条目3346条，其中生物过程（BP）2929条，细胞组成（CC）158条，分子功能（MF）259条；KEGG富集通路共198条。核心组方中的β-谷甾醇、6′-甲氧基-（9R）-9-醛金鸡聚糖-9-醛、黄芩苷、汉黄芩素、肉豆蔻酮等主要活性成分通过AGE-RAGE、IL-17、TNF等信号通路作用于TNF、IL6、AKT1等靶点蛋白。分子对接结果显示主要活性成分与核心靶点有着强烈结合活性。结论 徐昌伟教授治疗腰椎间盘突出症重在补益肝肾、活血化瘀、祛风除湿，兼顾护脾胃，用药以温平为主，通过多个通路作用于TNF、IL6、AKT1等靶点蛋白，并通过其抗炎、抗氧化、抗凋亡、免疫调节等多种机制治疗腰椎间盘突出症。
Abstract:
Objective To explore the medication rule and mechanism of Professor XU Changwei in the treatment of lumbar disc herniation. Methods The case data of Professor XU Changwei’s treatment of lumbar disc herniation in the outpatient department of Jingzhou Hospital of Traditional Chinese Medicine from 2010 to 2018 were collected. The frequency analysis and correlation analysis of the data were carried out by using the “Traditional Chinese Medicine Inheritance Support Platform (V3.5)” to obtain the core prescription, and the network pharmacology analysis was carried out. The TCMSP database was used to obtain the active components of the core prescription, the Gene Cards and OMIM databases were used to screen the disease targets and generate the Venn diagram, and the Cytoscape 3.9.2 software was used to construct the core network. Metascape online database was used to perform GO and KEGG functional enrichment analysis on the obtained key targets. The Autodock program was used for docking, and the visualization of the results was realized through PyMOL. Results A total of 200 cases were recorded. The prescriptions involved 179 traditional Chinese medicines, 10 of which were high-frequency drugs. Warm and mild drugs were the most used, mostly belonging to the three meridians of liver, spleen and kidney. Pungent, bitter and sweet were the most common tastes. 60 data were obtained by association rules, and 3 corecombinations were obtained by cluster analysis. There were 59 core active components, 144 target genes, 613 disease targets and 40 drug-disease common targets in the 4 core drugs (Chuanxiong, Danggui, Duzhong and Niuxi). There were 3346 GO functional enrichment items, including 2929 biological processes (BP), 158 cell composition (CC), and 259 molecular functions (MF). There were 198 KEGG enrichment pathways. The main active ingredients such as β-sitosterol, 6′-methoxy-(9R)-9-formyl-chickennan-9-aldehyde, baicalin, wogonin, and myristone in the core prescription act on TNF, IL6, AKT1 and other target proteins through AGE-RAGE, IL-17, TNF and other signaling pathways. Molecular docking results showed that the main active components had strong binding activity with the core target. Conclusion During the treatment of lumbar disc herniation, Professor XU Changwei is focused on tonifying liver and kidney, promoting blood circulation and removing blood stasis, expelling wind and removing dampness, taking into account the protection of spleen and stomach. The medication is mainly warm and calm, and acts on TNF, IL6, AKT1 and other target proteins through multiple pathways. And through its anti-inflammatory, anti-oxidation, anti-apoptosis, immune regulation and other mechanisms to treat lumbar disc herniation.

参考文献/References:

[1]覃鸿图.腰椎间盘突出症临床症状及体征与影像学区域定位的相关性研究[D].南宁:广西中医药大学,2023.[2]何玉钦,郭崇秋,黄亚丽,等.微针刀联合中医正骨手法治疗腰椎间盘突出症44例[J].中国中医药科技,2024,31(4):737-739.[3]张清福,乔宇,王昕,等.椎板间入路经皮椎间孔镜下髓核摘除术治疗L4/5腰椎间盘突出症的短期疗效分析[J].骨科,2024,15(2):169-172.[4]符碧峰,霍路遥,冯天笑,等.从经筋理论探讨腰椎间盘突出症的病因病机[J].天津中医药大学学报,2022,41(6):812-816.[5]聂颖,刘鑫,卢敏,等.卢敏教授“内外兼治”“筋骨并举”论治腰椎间盘突出症[J].湖南中医药大学学报,2022,42(9):1507-1511.[6]董丽丽,程倩,李凤.中医特色护理配合康复训练在保守治疗腰椎间盘突出症患者中的应用[J].四川中医,2024,42(3):208-213.[7]吕亚希,庞争争,朱元宵,等.麦肯基疗法联合腰部核心肌力训练治疗腰椎间盘突出症的疗效观察[J].中国康复,2020,35(5):244-246.[8]陈千,毛田,李聿琦,等.尪痹胶囊联合体外冲击波治疗风寒湿滞型腰椎间盘突出症40例[J].湖南中医杂志,2024,40(5):58-60.[9]曹盼举,田永衍,吴建民,等.腰椎间盘突出症古代中医文献溯源[J].陕西中医药大学学报,2018,41(3):16-18.[10]张朝驹,何川,刘伟,等.徐昌伟分期论治骨伤科疾患经验[J].湖北中医杂志,2015,37(5):31-32.[11]郝小刚,周国徽,闫宏旭,等.基于肝肾理论探讨腰椎间盘突出症[J].吉林中医药,2021,41(11):1412-1415.[12]高华东,邓艳君,费强,等.1961-2018年荆州市气候变化特征分析[J].湖北农业科学,2020,59(16):66-71.[13]陈宇.马武开从湿论治骨关节炎的经验[J].贵州中医药大学学报,2023,45(4):9-12.[14]向玮,卢思俭.卢思俭主任医师运用虫类药治痹经验[J].风湿病与关节炎,2020,9(9):45-47,52.[15]张美昱,王丽敏.虫类药在痹症治疗中的应用探寻[J].中国卫生标准管理,2023,14(21):132-136.[16]邓梦,马斌祥,关永林,等.基于网络药理学探讨“杜仲-牛膝”治疗腰椎间盘突出症的分子机制[J].中医药通报,2022,21(9):48-54.[17]张猛,梁一博,孔德奇.川芎联合酮咯酸氨丁三醇治疗慢性颈肩腰腿痛的效果观察[J].临床医学,2020,40(1):120-121.[18]Wang C,Gao Y,Zhang Z,et al.Ursolic acid protects chondrocytes, exhibits anti-inflammatory properties via regulation of the NF-κB/NLRP3 inflammasome pathway and ameliorates osteoarthritis[J].Biomed Pharmacother,2020,130:110568.[19]熊辉,李哲,于永洲,等.基于网络药理学和分子对接技术研究桑寄生抗炎的作用机制[J].承德医学院学报,2023,40(1):5-11.[20]Luo X,Liu J,Wang X,et al.Mechanism exploration of Osteoking in the treatment of lumbar disc herniation based on network pharmacology and molecular docking[J].J Orthop Surg Res,2024,19(1):88.[21]Gao S,Wang C,Qi L,et al.Bushen Huoxue Formula Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation in the Nucleus Pulposus Cells and Improves Intervertebral Disc Degeneration in Rats[J].J Inflamm Res,2024,17:121-136.[22]Li Z,Yang H,Hai Y,et al.Regulatory Effect of Inflammatory Mediators in Intervertebral Disc Degeneration[J].Mediators Inflamm,2023,2023:6210885.[23]Khan Z,Nath N,Rauf A,et al.Multifunctional roles and pharmacological potential of β-sitosterol: Emerging evidence toward clinical applications[J].Chem Biol Interact,2022,365:110117.[24]Zheng Y,Zhao J,Chang S,et al.β-Sitosterol Alleviates Neuropathic Pain by Affect Microglia Polarization through Inhibiting TLR4/NF-κB Signaling Pathway[J].J Neuroimmune Pharmacol,2023,18(4):690-703.[25]孙梦菲,欧阳竞锋,吴春阳,等.汉黄芩素减轻LPS诱导BV-2细胞炎症并保护SH-SY5Y细胞的机制[J].中国实验方剂学杂志,2024,30(20):62-69.[26]李会东,杨学钰,郭文帆,等.汉黄芩素调节炎症通路对膝骨关节炎大鼠炎性损伤的影响[J].世界临床药物,2023,44(6):552-560.[27]Chmiel M,Stompor-Goracy M.Promising Role of the Scutellaria baicalensis Root Hydroxyflavone-Baicalein in the Prevention and Treatment of Human Diseases[J].Int J Mol Sci,2023,24(5):4732.[28]Liu Y,Liu DK,Wang ZW,et al.Baicalein alleviates TNF-α-induced apoptosis of human nucleus pulposus cells through PI3K/AKT signaling pathway[J].J Orthop Surg Res,2023,18(1):292.[29]Gong Y,Qiu J,Jiang T,et al.Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis[J].Inflammopharmacology,2023,31(1):369-384.[30]朱炯,马雪建,岳宗进,等.基于网络药理学和分子对接探讨独活寄生汤治疗腰椎间盘突出症的作用机制[J/OL].颈腰痛杂志,1-14（2024-05-30）[2024-06-11].http://kns.cnki.net/kcms/detail/34.1117.R.20240529.1703.014.html.[31]宋雨.SIRT3调控线粒体稳态在AGEs诱导椎间盘退变中的作用及机制研究[D].武汉:华中科技大学,2020.[32]何川,庞启雄,陈洪卫,等.腰椎间盘突出症中医证型与血清炎性因子相关性分析[J].长江大学学报(自然科学版),2020,17(4):97-100.

相似文献/References:

[1]王钦奋,周仕国,刘国铭,等.腰椎间盘突出炎性因子与神经根性疼痛相关性研究[J].医学信息,2018,31(15):59.[doi:10.3969/j.issn.1006-1959.2018.15.019]
　WANG Qin-fen,ZHOU Shi-guo,LIU Guo-ming,et al.Correlation between Inflammatory Factors and Nerve Root Pain in Protrusion of Lumbar Intervertebral Disc[J].Journal of Medical Information,2018,31(05):59.[doi:10.3969/j.issn.1006-1959.2018.15.019]
[2]丁永国,李昌隆,孙建民,等.经皮穿刺椎间孔镜下应用TESSYS技术治疗 腰椎间盘突出症的临床疗效观察[J].医学信息,2018,31(16):38.[doi:10.3969/j.issn.1006-1959.2018.16.011]
　DING Yong-guo,LI Chang-long,SUN Jian-min,et al.Clinical Observation of Percutaneous Lumbar Disc Herniation Treated by TESSYS Technique under Transforaminal Endoscopy[J].Journal of Medical Information,2018,31(05):38.[doi:10.3969/j.issn.1006-1959.2018.16.011]
[3]刘国铭,林世水,周仕国.经皮椎间孔镜和椎板开窗减压术治疗 腰椎间盘突出症的临床疗效对比[J].医学信息,2018,31(17):66.[doi:10.3969/j.issn.1006-1959.2018.17.020]
　LIU Guo-ming,LIN Shi-shui,ZHOU Shi-guo.Comparison of Clinical Outcomes between Percutaneous Transforaminal Decompression and Decompression of Vertebral Lamina Fenestration in the Treatment of Lumbar Disc Herniation[J].Journal of Medical Information,2018,31(05):66.[doi:10.3969/j.issn.1006-1959.2018.17.020]
[4]张占录.腰椎间盘突出合并相应节段椎管狭窄症的微创手术治疗研究[J].医学信息,2019,32(04):174.[doi:10.3969/j.issn.1006-1959.2019.04.058]
　ZHANG Zhan-lu.Minimally Invasive Surgery for Lumbar Disc Herniation with Corresponding Segmental Spinal Stenosis[J].Journal of Medical Information,2019,32(05):174.[doi:10.3969/j.issn.1006-1959.2019.04.058]
[5]陈华荣,温桃芳,何朝洪,等.椎间孔镜下椎间盘髓核摘除治疗腰椎间盘突出症的疗效[J].医学信息,2019,32(23):112.[doi:10.3969/j.issn.1006-1959.2019.00.031]
　CHEN Hua-rong,WEN Tao-fang,HE Chao-hong,et al.Effect of Intervertebral Disc Nucleus Pulposus Removal on Lumbar Disc Herniation[J].Journal of Medical Information,2019,32(05):112.[doi:10.3969/j.issn.1006-1959.2019.00.031]
[6]王 斐.小针刀联合推拿按摩治疗腰椎间盘突出症的效果[J].医学信息,2020,33(03):151.[doi:10.3969/j.issn.1006-1959.2020.03.049]
　WANG Fei.Effect of Small Needle Knife Combined with Massage on Lumbar Disc Herniation[J].Journal of Medical Information,2020,33(05):151.[doi:10.3969/j.issn.1006-1959.2020.03.049]
[7]赵名娟,张金涛,徐玉振.误诊为脊髓压迫症的脊肌萎缩症1例[J].医学信息,2020,33(12):182.[doi:10.3969/j.issn.1006-1959.2020.12.061]
[8]戴志鹏.止痛通痹液治疗腰椎间盘突出症的效果及对患者血清炎症因子、PGE2水平的影响[J].医学信息,2020,33(24):154.[doi:10.3969/j.issn.1006-1959.2020.24.044]
　DAI Zhi-peng.Effect of Zhitongtongbi Liquid in the Treatment of Prolapse of Lumbar Intervertebral Disc and Its Effect on the Levels of Serum Inflammatory Factors and PGE2 in Patients[J].Journal of Medical Information,2020,33(05):154.[doi:10.3969/j.issn.1006-1959.2020.24.044]
[9]陈天宁,邵 进.腰椎间盘突出症阶梯治疗方案的研究现状[J].医学信息,2021,34(17):53.[doi:10.3969/j.issn.1006-1959.2021.17.014]
　CHEN Tian-ning,SHAO Jin.Current Status of Research on Step-by-step Treatment of Lumbar Disc Herniation[J].Journal of Medical Information,2021,34(05):53.[doi:10.3969/j.issn.1006-1959.2021.17.014]
[10]程景山.经皮椎间孔镜技术在腰椎病变中的应用[J].医学信息,2022,35(12):81.[doi:10.3969/j.issn.1006-1959.2022.12.019]
　CHENG Jing-shan.Application of Transforaminal Endoscopic Spine System technique in Lumbar Lesions[J].Journal of Medical Information,2022,35(05):81.[doi:10.3969/j.issn.1006-1959.2022.12.019]

更新日期/Last Update: 1900-01-01